Furthermore, we demonstrated that EpCAM promoted lung cancer cells invasion and migration, and the impaired tumor cell invasion and migration abilities following MTA1-silenging can be rescued by overexpressing EpCAM. Here, EPCAM is linked to lung carcinoma.